{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:21:44Z","timestamp":1794360104801,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Creutzfeldt-Jakob Disease (CJD) is the most common prion disease in humans causing a rapidly progressive neurological decline and dementia and is invariably fatal. The familial forms (genetic CJD, gCJD) are caused by mutations in the <jats:italic>PRNP<\/jats:italic> gene encoding for the prion protein (PrP). In Israel, there is a large cluster of gCJD cases, carriers of an E200K mutation in the <jats:italic>PRNP<\/jats:italic> gene, and therefore the largest population of at-risk individuals in the world. The mutation is not necessarily sufficient for the formation and accumulation of the pathological prion protein (PrP<jats:sup>sc<\/jats:sup>), suggesting that other, genetic and non-genetic factors affect the age at symptoms onset. Here we present the protocol of a cross-sectional and longitudinal natural history study of gCJD patients and first-degree relatives of gCJD patients, aiming to identify biological markers of preclinical CJD and risk factors for phenoconversion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study has two groups: Patients diagnosed with gCJD, and first-degree healthy relatives (HR) (both carriers and non-carriers of the E200K mutation in the <jats:italic>PRNP<\/jats:italic> gene) of patients diagnosed with gCJD. At baseline, and at the end of every year, healthy participants are invited for an \u201cin-depth\u201d visit, which includes a clinical evaluation, blood and urine collection, gait assessment, brain MRI, lumbar puncture (LP), and Polysomnography (PSG). At 6 months from baseline, and then halfway through each year, participants are invited for a \u201cbrief\u201d visit, which includes a clinical evaluation, short cognitive assessment, and blood and urine collection. gCJD patients will be invited for one \u201cin-depth\u201d visit, similar to the baseline visit of healthy relatives.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This continuous follow-up of the participants and the frequent assessments will allow early identification and diagnosis in case of conversion into disease. The knowledge generated from this study is likely to advance the understanding of the underlying clinicopathological processes that occur at the very beginning of CJD, as well as potential genetic and environmental risk factors for the development of the disease, therefore advancing the development of safe and efficient interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study is an observational study. It has registered retrospectively in <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\">https:\/\/clinicaltrials.gov\/<\/jats:ext-link> and has been assigned an identification number NCT05746715.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03193-8","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T07:02:53Z","timestamp":1681714973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol"],"prefix":"10.1186","volume":"23","author":[{"given":"Noa","family":"Bregman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Shiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitit","family":"Kav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Gana-Weisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Glinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Aizenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna Ben","family":"Bashat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifat","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Mirelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurit","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"3193_CR1","doi-asserted-by":"crossref","unstructured":"Prusiner SB. Molecular biology of prion diseases.Science. 1991;252(5012):1515\u201322.","DOI":"10.1126\/science.1675487"},{"key":"3193_CR2","doi-asserted-by":"crossref","unstructured":"Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in sephardic Jews of libyan and non-libyan origin. Lancet. 1990;8(8715):637\u20138.","DOI":"10.1016\/0140-6736(90)93443-S"},{"key":"3193_CR3","doi-asserted-by":"crossref","unstructured":"Korczyn AD. Prion diseases. Curr Opin Neurol. 1997;10(3):273\u201381.","DOI":"10.1097\/00019052-199706000-00018"},{"key":"3193_CR4","doi-asserted-by":"crossref","unstructured":"Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol. 1986;20(5):597\u2013602.","DOI":"10.1002\/ana.410200507"},{"key":"3193_CR5","doi-asserted-by":"crossref","unstructured":"Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology. 1994;44(9):1683\u20136.","DOI":"10.1212\/WNL.44.9.1683"},{"key":"3193_CR6","doi-asserted-by":"crossref","unstructured":"Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem. 2001;76(6):1654\u201362.","DOI":"10.1046\/j.1471-4159.2001.00195.x"},{"key":"3193_CR7","doi-asserted-by":"crossref","unstructured":"Poleggi A, van der Lee S, Capellari S, Puopolo M, Ladogana A, De Pascali E, et al. Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by the CYP4X1 gene. J Neurol Neurosurg Psychiatr. 2018;89(12):1243\u20139.","DOI":"10.1136\/jnnp-2018-318756"},{"key":"3193_CR8","doi-asserted-by":"crossref","unstructured":"Rosenmann H, Kahana E, Korczyn AD, Kahana I, Chapman J, Gabizon R. Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease. Neurology. 1999 12;53(6):1328\u20139.","DOI":"10.1212\/WNL.53.6.1328"},{"key":"3193_CR9","doi-asserted-by":"crossref","unstructured":"Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G et al. Ascertainment bias causes false signal of anticipation in genetic prion disease. Am J Hum Genet. 2014 2;95(4):371\u201382.","DOI":"10.1016\/j.ajhg.2014.09.003"},{"key":"3193_CR10","doi-asserted-by":"crossref","unstructured":"Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018 24;91(4):e331\u20138.","DOI":"10.1212\/WNL.0000000000005860"},{"key":"3193_CR11","doi-asserted-by":"crossref","unstructured":"Kang H-E, Mo Y, Abd Rahim R, Lee H-M, Ryou C. Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion.Biomed Res Int. 2017;2017:5413936.","DOI":"10.1155\/2017\/5413936"},{"key":"3193_CR12","doi-asserted-by":"crossref","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175\u20138.","DOI":"10.1038\/nm.2294"},{"key":"3193_CR13","doi-asserted-by":"crossref","unstructured":"Groveman BR, Orr\u00fa CD, Hughson AG, Bongianni M, Fiorini M, Imperiale D, et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol. 2017;4(2):139\u201344.","DOI":"10.1002\/acn3.378"},{"key":"3193_CR14","doi-asserted-by":"crossref","unstructured":"Franceschini A, Baiardi S, Hughson AG, McKenzie N, Moda F, Rossi M, et al. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep. 2017;6(1):10655.","DOI":"10.1038\/s41598-017-10922-w"},{"key":"3193_CR15","doi-asserted-by":"crossref","unstructured":"Foutz A, Appleby BS, Hamlin C, Liu X, Yang S, Cohen Y, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol. 2017;81(1):79\u201392.","DOI":"10.1002\/ana.24833"},{"key":"3193_CR16","doi-asserted-by":"crossref","unstructured":"Bongianni M, Orr\u00f9 C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G et al. Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples. JAMA Neurol. 2017 1;74(2):155\u201362.","DOI":"10.1001\/jamaneurol.2016.4614"},{"key":"3193_CR17","doi-asserted-by":"crossref","unstructured":"Fiorini M, Iselle G, Perra D, Bongianni M, Capaldi S, Sacchetto L et al. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD. Int J Mol Sci. 2020 30;21(3).","DOI":"10.3390\/ijms21030880"},{"key":"3193_CR18","doi-asserted-by":"crossref","unstructured":"Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, et al. Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. J Neurol. 2015;262(3):604\u201313.","DOI":"10.1007\/s00415-014-7615-1"},{"key":"3193_CR19","doi-asserted-by":"crossref","unstructured":"Steinacker P, Blennow K, Halbgebauer S, Shi S, Ruf V, Oeckl P et al. Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.Sci Rep. 2016;6:38737.","DOI":"10.1038\/srep38737"},{"key":"3193_CR20","doi-asserted-by":"crossref","unstructured":"Ju Y-ES, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology\u2013a bidirectional relationship. Nat Rev Neurol. 2014;10(2):115\u20139.","DOI":"10.1038\/nrneurol.2013.269"},{"key":"3193_CR21","doi-asserted-by":"crossref","unstructured":"Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med. 2015;13:47:e148.","DOI":"10.1038\/emm.2014.121"},{"key":"3193_CR22","doi-asserted-by":"crossref","unstructured":"Pavese N. Imaging the aetiology of sleep disorders in dementia and Parkinson\u2019s disease. Curr Neurol Neurosci Rep. 2014;14(12):501.","DOI":"10.1007\/s11910-014-0501-5"},{"issue":"2","key":"3193_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JPD-130301","volume":"4","author":"W Schrempf","year":"2014","unstructured":"Schrempf W, Brandt MD, Storch A, Reichmann H. Sleep disorders in Parkinson\u2019s disease. J Parkinsons Dis. 2014;4(2):211\u201321.","journal-title":"J Parkinsons Dis"},{"key":"3193_CR24","doi-asserted-by":"crossref","unstructured":"Postuma RB, Gagnon J-F, Montplaisir J. Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med. 2013;14(8):763\u20137.","DOI":"10.1016\/j.sleep.2012.09.001"},{"key":"3193_CR25","doi-asserted-by":"crossref","unstructured":"Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77(5):830\u20139.","DOI":"10.1002\/ana.24385"},{"key":"3193_CR26","doi-asserted-by":"crossref","unstructured":"Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord. 2001;16(4):622\u201330.","DOI":"10.1002\/mds.1120"},{"key":"3193_CR27","doi-asserted-by":"crossref","unstructured":"Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. 2010;10(6):494\u20139.","DOI":"10.1212\/WNL.0b013e3181ec7fac"},{"key":"3193_CR28","doi-asserted-by":"crossref","unstructured":"Ju Y-ES, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587\u201393.","DOI":"10.1001\/jamaneurol.2013.2334"},{"key":"3193_CR29","doi-asserted-by":"crossref","unstructured":"Takada LT, Geschwind MD. Prion diseases. Semin Neurol. 2013;33(4):348\u201356.","DOI":"10.1055\/s-0033-1359314"},{"key":"3193_CR30","doi-asserted-by":"crossref","unstructured":"Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15\u201354.","DOI":"10.1111\/j.1749-6632.2009.05115.x"},{"key":"3193_CR31","doi-asserted-by":"crossref","unstructured":"Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, et al. Sleep Pathology in Creutzfeldt-Jakob Disease. J Clin Sleep Med. 2016;15(7):1033\u20139.","DOI":"10.5664\/jcsm.5944"},{"key":"3193_CR32","doi-asserted-by":"crossref","unstructured":"Landolt HP, Glatzel M, Bl\u00e4ttler T, Achermann P, Roth C, Mathis J, et al. Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;9(9):1418\u201324.","DOI":"10.1212\/01.wnl.0000210445.16135.56"},{"key":"3193_CR33","doi-asserted-by":"crossref","unstructured":"El Sammak S, Attarian H, Taype-Roberts C, Standlee J. REM sleep behavior disorder as a remote precedent to Creutzfeldt-Jakob disease. Neurol Sci. 2022;43(9):5647\u20139.","DOI":"10.1007\/s10072-022-06147-z"},{"key":"3193_CR34","doi-asserted-by":"crossref","unstructured":"Spudich S, Mastrianni JA, Wrensch M, Gabizon R, Meiner Z, Kahana I, et al. Complete penetrance of Creutzfeldt-Jakob disease in libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med. 1995;1(6):607\u201313.","DOI":"10.1007\/BF03401601"},{"key":"3193_CR35","doi-asserted-by":"crossref","unstructured":"Minikel EV, Vallabh SM, Orseth MC, Brandel J-P, Ha\u00efk S, Laplanche J-L, et al. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology. 2019;9(2):e125\u201334.","DOI":"10.1212\/WNL.0000000000007745"},{"key":"3193_CR36","doi-asserted-by":"crossref","unstructured":"Thompson AGB, Lowe J, Fox Z, Lukic A, Porter M-C, Ford L, et al. The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain. 2013;136(Pt 4):1116\u201327.","DOI":"10.1093\/brain\/awt048"},{"key":"3193_CR37","doi-asserted-by":"crossref","unstructured":"Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample.Neurology. 2011;77(13):1272\u20135.","DOI":"10.1212\/WNL.0b013e318230208a"},{"issue":"7","key":"3193_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/13803395.2015.1065958","volume":"37","author":"G Kav\u00e9","year":"2015","unstructured":"Kav\u00e9 G, Knafo-Noam A. Lifespan development of phonemic and semantic fluency: Universal increase, differential decrease. J Clin Exp Neuropsychol. 2015;37(7):751\u201363.","journal-title":"J Clin Exp Neuropsychol"},{"key":"3193_CR39","doi-asserted-by":"crossref","unstructured":"Brown T, Bourne R, Sutton E, Wigg S, Burgess D, Glass S, et al. The reliability of three visual perception tests used to assess adults. Percept Mot Skills. 2010;111(1):45\u201359.","DOI":"10.2466\/03.24.27.PMS.111.4.45-59"},{"key":"3193_CR40","doi-asserted-by":"crossref","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;12(11):1621\u20136.","DOI":"10.1212\/WNL.55.11.1621"},{"key":"3193_CR41","doi-asserted-by":"crossref","unstructured":"Smith SR, Servesco AM, Edwards JW, Rahban R, Barazani S, Nowinski LA et al. Exploring the validity of the comprehensive trail making test.Clin Neuropsychol. 2008;22(3):507\u201318.","DOI":"10.1080\/13854040701399269"},{"key":"3193_CR42","doi-asserted-by":"crossref","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371.","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"3193_CR43","doi-asserted-by":"crossref","unstructured":"Spielberger CD. Notes and comments trait-state anxiety and motor behavior.J Mot Behav. 1971;3(3):265\u201379.","DOI":"10.1080\/00222895.1971.10734907"},{"key":"3193_CR44","unstructured":"Unable to find information for 14001915."},{"key":"3193_CR45","doi-asserted-by":"crossref","unstructured":"Goldberg LR. Analyses of Digman\u2019s child-personality data: derivation of big-five factor scores from each of six samples. J Pers. 2001;69(5):709\u201343.","DOI":"10.1111\/1467-6494.695161"},{"key":"3193_CR46","doi-asserted-by":"crossref","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30(12):1600\u201311.","DOI":"10.1002\/mds.26431"}],"updated-by":[{"DOI":"10.1186\/s12883-023-03272-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000}}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03193-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03193-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T11:04:28Z","timestamp":1686654268000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03193-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3193"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03193-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12883-023-03272-w","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"29 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12883-023-03272-w","URL":"https:\/\/doi.org\/10.1186\/s12883-023-03272-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethical committee and is being performed according to the Principles of the Declaration of Helsinki. All participants give their informed written consent prior to participation and after making sure they or their legal guardian understand the consent and to the PI judgment (N.B.) are eligible to sign an informed consent.All methods are carried out in accordance with relevant guidelines and regulations.All experimental protocols were approved by the Tel Aviv Medical Center IRB and by the Israeli Ministry of Health IRB (IRB number 0215\u2009\u2212\u200918 TLV, protocol version #3, 27-01-19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}